CorMedix Inc (NASDAQ:CRMD) price on current trading day, fall -0.46% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $10.92.
A look at the stock’s price movement, the level at last check in today’s session was $10.97, moving within a range at $10.76 and $11.32. The beta value (5-Year monthly) was 1.529. Turning to its 52-week performance, $13.85 and $3.61 were the 52-week high and 52-week low respectively. Overall, CRMD moved -2.28% over the past month.
CorMedix Inc’s market cap currently stands at around $662.60 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-24.
Analysts have a consensus estimate of 28.34M for the company’s revenue for the quarter, with a low and high estimate of 20.5M and 31.1M respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRMD is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend CRMD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRMD’s current price about 5.33% and 0.93% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.25, while 7-day volatility ratio is 5.37% and 6.22% in the 30-day chart. Further, CorMedix Inc (CRMD) has a beta value of 1.34, and an average true range (ATR) of 0.62. Analysts have given the company’s stock an average 52-week price target of $9, forecast between a low of $9 and high of $9. Looking at the price targets, the low is 17.58% off recent price level in today’s trading while to achieve the yearly target high, it has to move 17.58%. Nonetheless, investors will most likely welcome a 17.58% jump to $9 which is the analysts’ median price.
If we refocus on CorMedix Inc (NASDAQ:CRMD), historical trading data shows that trading volumes averaged 0.8 over the past 10 days and 1.02 million over the past 3 months. The company’s latest data on shares outstanding shows there are 60.68 million shares.
The 2.35% of CorMedix Inc’s shares are in the hands of company insiders while institutional holders own 37.73% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.88 million on 2025-02-28, giving us a short ratio of 9.17. The data shows that as of 2025-02-28 short interest in CorMedix Inc (CRMD) stood at 1298.9999999999998 of shares outstanding, with shares short rising to 7.18 million registered in 2025-01-31. Current price change has pushed the stock 34.81% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRMD stock continues to rise going into the next quarter.
